229 related articles for article (PubMed ID: 20449698)
41. Ranolazine: clinical applications and therapeutic basis.
Hawwa N; Menon V
Am J Cardiovasc Drugs; 2013 Feb; 13(1):5-16. PubMed ID: 23335347
[TBL] [Abstract][Full Text] [Related]
42. Ranolazine in the management of chronic stable angina.
Zerumsky K; McBride BF
Am J Health Syst Pharm; 2006 Dec; 63(23):2331-8. PubMed ID: 17106005
[TBL] [Abstract][Full Text] [Related]
43. Anti-anginal and anti-ischemic effects of late sodium current inhibition.
Wimmer NJ; Stone PH
Cardiovasc Drugs Ther; 2013 Feb; 27(1):69-77. PubMed ID: 23247666
[TBL] [Abstract][Full Text] [Related]
44. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
[TBL] [Abstract][Full Text] [Related]
45. Ranolazine for chronic stable angina.
Nash DT; Nash SD
Lancet; 2008 Oct; 372(9646):1335-41. PubMed ID: 18929905
[TBL] [Abstract][Full Text] [Related]
46. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
Thadani U
Expert Opin Pharmacother; 2012 Dec; 13(17):2555-63. PubMed ID: 23121448
[TBL] [Abstract][Full Text] [Related]
47. Utility of ranolazine in chronic stable angina patients.
Patel PD; Arora RR
Vasc Health Risk Manag; 2008; 4(4):819-24. PubMed ID: 19065998
[TBL] [Abstract][Full Text] [Related]
48. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
49. [Symptomatic coronary heart disease therapy: ranolazine reduces frequency of angina in diabetic patients].
MMW Fortschr Med; 2013 Mar; 155 Spec No 1(1):20. PubMed ID: 24260912
[No Abstract] [Full Text] [Related]
50. The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.
Di Monaco A; Sestito A
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1611-36. PubMed ID: 23161033
[TBL] [Abstract][Full Text] [Related]
51. The evolving role of medical therapy for chronic stable angina.
Eid F; Boden WE
Curr Cardiol Rep; 2008 Jul; 10(4):263-71. PubMed ID: 18611360
[TBL] [Abstract][Full Text] [Related]
52. Update on ranolazine in the management of angina.
Codolosa JN; Acharjee S; Figueredo VM
Vasc Health Risk Manag; 2014; 10():353-62. PubMed ID: 25028555
[TBL] [Abstract][Full Text] [Related]
53. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
[TBL] [Abstract][Full Text] [Related]
54. Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.
Kiernan TJ; Prasad A; Gersh BJ
Rev Cardiovasc Med; 2007; 8(4):234-9. PubMed ID: 18192947
[No Abstract] [Full Text] [Related]
55. Ranolazine: a new approach to treating an old problem.
Reddy BM; Weintraub HS; Schwartzbard AZ
Tex Heart Inst J; 2010; 37(6):641-7. PubMed ID: 21224931
[TBL] [Abstract][Full Text] [Related]
56. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
57. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
Lee L; Horowitz J; Frenneaux M
Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
[TBL] [Abstract][Full Text] [Related]
58. Ranolazine as add-on therapy for patients with severe chronic angina.
Pechlaner C; Wiedermann C
JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113811
[No Abstract] [Full Text] [Related]
59. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions.
Chaitman BR
Circulation; 2006 May; 113(20):2462-72. PubMed ID: 16717165
[No Abstract] [Full Text] [Related]
60. Ranolazine, a novel agent for chronic stable angina.
Gaffney SM
Pharmacotherapy; 2006 Jan; 26(1):135-42. PubMed ID: 16506355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
